GSK-3β coordinates axonal microtubule organization through Shot and Tau. [PDF]
Voelzmann A +8 more
europepmc +1 more source
IGF1/IGF-1R promotes hepatocellular carcinoma progression by activating the Akt/GSK-3β pathway. [PDF]
Liang J +5 more
europepmc +1 more source
TRIM37 interacts with PTEN to promote progression of hepatocellular carcinoma cells by modulating AKT/GSK-3β/β-Catenin pathway. [PDF]
Wang Q, Zhang X, Zhang J.
europepmc +1 more source
Selective 7‑Azaindole Modulators Targeting Fyn and GSK-3β for Dual-Target Neuromodulation. [PDF]
Shi H, Li Y, Liang SH.
europepmc +1 more source
Moxa-combustion byproducts improve cognitive function via olfactory-mediated modulation of the GSK-3β/CREB pathway. [PDF]
Wu JW, Liu YJ, He J, Shi YQ, Zhao BX.
europepmc +1 more source
Harnessing GSK-3β inhibition for lung cancer therapy: emerging opportunities and challenges. [PDF]
Hassanein EHM +4 more
europepmc +1 more source
miR-24-3p promotes spinal cord injury repair in rats by inhibiting ferroptosis <i>via</i> targeting GSK-3β. [PDF]
Wei D +10 more
europepmc +1 more source
TMEM88 modulates the proliferation and metastasis of HCC via the GSK-3β/β-catenin pathway. [PDF]
Zhang J +8 more
europepmc +1 more source
Machine learning guided virtual screening of FDA approved drugs targeting GSK-3β in Alzheimer's disease. [PDF]
Kumar BS +7 more
europepmc +1 more source
FBXO9 mediated the ubiquitination and degradation of YAP in a GSK-3β-dependent manner. [PDF]
Jin Y, Xue Y, Yao J, Xu C, Yu R.
europepmc +1 more source

